Oct 29, 2025 08:31AM ProPhase Labs publishes esophageal cancer study in gastroenterology journal

Sep 23, 2025 08:05AM ProPhase Labs covid-19 testing units file for Chapter 11 bankruptcy

Aug 13, 2025 06:59PM ProPhase Labs (PRPH) Tops Q2 EPS by 4c

Aug 12, 2025 08:00AM ProPhase Labs receives USPTO patent for esophageal cancer risk assessment

Jul 23, 2025 08:02AM ProPhase Labs closes $3 million convertible notes financing

Jul 21, 2025 08:00AM ProPhase Labs board authorizes reverse merger exploration with crypto company

Jun 26, 2025 07:30AM ProPhase Labs (PRPH) Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

Jun 6, 2025 07:01AM ProPhase Labs (PRPH) Announces Formation of Clinical Science Advisory Board

May 20, 2025 04:24PM ProPhase Labs (PRPH) Tops Q1 EPS by 5c

Feb 25, 2025 08:05AM ProPhase Labs (PRPH) Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

Feb 18, 2025 08:04AM ProPhase Labs (PRPH) Appoints Stuart Hollenshead as COO

Feb 13, 2025 05:09PM ProPhase Labs (PRPH) appoints new COO amid executive changes

Nov 8, 2024 06:09AM ProPhase Labs (PRPH) Prices 4.17M Share Offering at $0.72/sh

Nov 7, 2024 04:06PM ProPhase Labs (PRPH) Announces Proposed Share Offering

Oct 17, 2024 08:01AM ProPhase Labs (PRPH) Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Sep 11, 2024 01:00PM Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Aug 13, 2024 08:03AM ProPhase Labs (PRPH) Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer Test